OXFORD DRUG DESIGN LIMITED
is not in process of liquidation on Jun 1, 2024
Private limited company
United Kingdom • 17 Oct 2001 (23 years ago)
Summary
- INHIBOX LIMITED
- Active
United Kingdom
04305857- Primary:
- #7211 - Research and experimental development on biotechnology
Contact details
Officers
United Kingdom
Director
Appointed on18 Nov 2001
Country of residenceUnited Kingdom
Financial reports
Find out all the information about the company
Get full access to the data
Events
Old value
Name changeINHIBOX LIMITED
Additional data
- First accounts made up to31 Dec 2023
due by 30 Sep 2024 - Last accounts made up to31 Dec 2022
- CategoryTOTAL EXEMPTION FULL
- Next statement date29 Oct 2024
due by 12 Nov 2024 - Last statement dated29 Oct 2023
- Next returns datedue by 26 Nov 2016
- Last returns dated29 Oct 2015
Related companies by address
United Kingdom
ENGLAND, OXFORD, OXFORD CENTRE FOR INNOVATION, NEW ROAD, OX1 1BY
OXFORD ANTIBIOTICS LIMITEDIF OXFORD LTD.CARD MEDIC LIMITEDVISUAL MEANING LIMITEDPRINTPOOL ADDITIVE MANUFACTURING LTDOPTELLUM LTDKENDA TECHNOLOGIES LTDSQW GROUP LIMITEDSQW LIMITEDRelated companies by officers
United Kingdom
Secretary
RED LION COURT (HEREFORD) LIMITEDREOX LIMITEDSALIGO PROJECTS LIMITEDFrequently asked questions
Where is OXFORD DRUG DESIGN LIMITED's headquarters?
OXFORD DRUG DESIGN LIMITED's headquarters is located at ENGLAND, OXFORD, OXFORD CENTRE FOR INNOVATION, NEW ROAD, OX1 1BY
What is OXFORD DRUG DESIGN LIMITED's industry?
OXFORD DRUG DESIGN LIMITED is in the industry of Research and experimental development on biotechnology
What year was OXFORD DRUG DESIGN LIMITED started?
OXFORD DRUG DESIGN LIMITED was started in 2001
Sources: Companies House
Your trusted source for business data
English, USA